|Articles|November 15, 2003

Keeping kids in the game

With the change in the weather, kids have settled back into the school routine and many fall sports have started up again. Unfortunately, along with the increase in organized and pick-up sports, more sports-related eye injuries are possible. More than 40,000 eye injuries each year are attributed to sports trauma.

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Keeping kids in the game

Related Content

Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection

FDA guidance to help accelerate cell and gene therapies

The Residency Report: Cardiovascular risk scores as a window into ocular disease

Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema

TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis

Latest CME

(COPE Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

(CME Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

(COPE Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

Neurotrophic Keratitis Insights: An Interactive Corneal Sensitivity Testing Workshop

(CME Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

Retina Updates in Montréal

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

FDA guidance to help accelerate cell and gene therapies

Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection

Treatment Goals in Retinal Vascular Diseases

The Residency Report: Cardiovascular risk scores as a window into ocular disease

Durability and Unmet Needs in Retinal Vascular Diseases